Literature DB >> 22160835

The role of body mass index and other body composition parameters in early post-transplant complications in patients undergoing allogeneic stem cell transplantation with busulfan-cyclophosphamide conditioning.

Gülsan Türköz Sucak1, Elif Suyanı, Nuran Ahu Baysal, Şermin Altındal, Merih Kizil Çakar, Şahika Zeynep Akı, Zeynep Arzu Yeğin, Nevin Şanlıer.   

Abstract

Patients with impaired nutritional status may show increased risk of hematopoietic stem cell transplantation (HSCT)-related complications. This study was conducted to determine whether body mass index (BMI) and other body composition parameters, such as lean body mass index (LBMI) and body fat mass (BFM), are associated with early post-transplantation toxicity and mortality in allogeneic HSCT recipients. The records of 71 patients diagnosed with acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), or myelodysplastic leukemia (MDS) who had undergone allogeneic HSCT with a conditioning regimen of busulfan-cyclophosphamide (Bu-Cy), between September 2003 and January 2009 at the Stem Cell Transplantation Unit of Gazi University Hospital were retrospectively evaluated. BMI was found to be negatively correlated with the NCI grade of mucositis, cardiotoxicity, emesis, and hyperglycemia, and with the number of erythrocyte transfusions. LBMI was also negatively correlated with the number of erythrocyte transfusions, cardiotoxicity, emesis, and hyperglycemia. BFM was negatively correlated with the day of neutrophil engraftment, and NCI grade of mucositis. Nutritional status did not have an impact on overall survival (OS), progression-free survival (PFS), or 100-day transplant related mortality (TRM).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22160835     DOI: 10.1007/s12185-011-0980-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  16 in total

Review 1.  Impact of nutrition on quality of life during cancer.

Authors:  Mónica María Marín Caro; Alessandro Laviano; Claude Pichard
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2007-07       Impact factor: 4.294

2.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

3.  A reanalysis of the factors influencing basal metabolic rate in normal adults.

Authors:  J J Cunningham
Journal:  Am J Clin Nutr       Date:  1980-11       Impact factor: 7.045

Review 4.  Hospital length of stay and nutritional status.

Authors:  Ursula G Kyle; Laurence Genton; Claude Pichard
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2005-07       Impact factor: 4.294

5.  Impact of patient weight on non-relapse mortality after marrow transplantation.

Authors:  H J Deeg; K Seidel; B Bruemmer; M S Pepe; F R Appelbaum
Journal:  Bone Marrow Transplant       Date:  1995-03       Impact factor: 5.483

6.  Inferior outcomes for overweight children undergoing allogeneic stem cell transplantation.

Authors:  Sean Bulley; Adam Gassas; L Lee Dupuis; Richard Aplenc; Joseph Beyene; Mark L Greenberg; John J Doyle; Lillian Sung
Journal:  Br J Haematol       Date:  2007-11-19       Impact factor: 6.998

7.  A low body mass index is correlated with poor survival after allogeneic stem cell transplantation.

Authors:  Katarina Le Blanc; Olle Ringdén; Mats Remberger
Journal:  Haematologica       Date:  2003-09       Impact factor: 9.941

Review 8.  Impact of nutrition on pharmacokinetics of anti-neoplastic agents.

Authors:  D J Murry; L Riva; D G Poplack
Journal:  Int J Cancer Suppl       Date:  1998

9.  Evaluation of nutritional status in patients undergoing hematopoietic SCT.

Authors:  M Hadjibabaie; M Iravani; M Taghizadeh; A Ataie-Jafari; A R Shamshiri; S A Mousavi; K Alimoghaddam; S Hosseini; A Ghavamzadeh
Journal:  Bone Marrow Transplant       Date:  2008-07-07       Impact factor: 5.483

Review 10.  Body composition measurements: interpretation finally made easy for clinical use.

Authors:  Ursula G Kyle; Antonio Piccoli; Claude Pichard
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2003-07       Impact factor: 4.294

View more
  10 in total

1.  The impact of pre-transplant body weight on short- and long-term outcomes after allogeneic hematopoietic cell transplantation in adults using different weight classification tools.

Authors:  P Urbain; G Ihorst; J Finke; H Bertz
Journal:  Bone Marrow Transplant       Date:  2015-10-05       Impact factor: 5.483

2.  Impact of being overweight on outcomes of hematopoietic SCT: a meta-analysis.

Authors:  M Nakao; D Chihara; A Niimi; R Ueda; H Tanaka; Y Morishima; K Matsuo
Journal:  Bone Marrow Transplant       Date:  2013-08-19       Impact factor: 5.483

Review 3.  Revisiting nutritional support for allogeneic hematologic stem cell transplantation-a systematic review.

Authors:  A Baumgartner; A Bargetzi; N Zueger; M Bargetzi; M Medinger; L Bounoure; F Gomes; Z Stanga; B Mueller; P Schuetz
Journal:  Bone Marrow Transplant       Date:  2017-01-09       Impact factor: 5.483

4.  Molecular mechanism of prostate cancer cell apoptosis induced by busulfan via adjustment of androgen receptor phosphatization.

Authors:  Jun Liu; Guojun Jiang; Aiping Yang; Guohui Yang; Wenjuan Yang; Yi Fang
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

5.  Baseline body mass index among children and adults undergoing allogeneic hematopoietic cell transplantation: clinical characteristics and outcomes.

Authors:  M Gleimer; Y Li; L Chang; S Paczesny; D A Hanauer; D G Frame; C A Byersdorfer; P R Reddy; T M Braun; S W Choi
Journal:  Bone Marrow Transplant       Date:  2014-12-22       Impact factor: 5.483

6.  Pre-transplant arm muscle area: a simple measure to identify patients at risk.

Authors:  Ana Cláudia Thomaz; Carolline Ilha Silvério; Denise Johnsson Campos; Elena Emilia Moreira Kieuteka; Estela Iraci Rabito; Vaneuza Araújo Moreira Funke; Regina Maria Vilela
Journal:  Support Care Cancer       Date:  2015-07-21       Impact factor: 3.603

7.  Impact of clinical pharmacist-based parenteral nutrition service for bone marrow transplantation patients: a randomized clinical trial.

Authors:  Maryam Mousavi; Alireza Hayatshahi; Amir Sarayani; Molouk Hadjibabaie; Mohammadreza Javadi; Hassan Torkamandi; Kheirollah Gholami; Ardeshir Ghavamzadeh
Journal:  Support Care Cancer       Date:  2013-08-16       Impact factor: 3.603

8.  Nutritional status of patients submitted to transplantation of allogeneic hematopoietic stem cells: a retrospective study.

Authors:  Erika Elias Ferreira; Daiane Cristina Guerra; Kátia Baluz; Wander de Resende Furtado; Luis Fernando da Silva Bouzas
Journal:  Rev Bras Hematol Hemoter       Date:  2014-07-18

9.  Weight Loss and Decrease of Body Mass Index during Allogeneic Stem Cell Transplantation Are Common Events with Limited Clinical Impact.

Authors:  Christina T Rieger; Isabel Wischumerski; Christian Rust; Michael Fiegl
Journal:  PLoS One       Date:  2015-12-18       Impact factor: 3.240

10.  Endogenous glucagon-like peptide- 1 and 2 are essential for regeneration after acute intestinal injury in mice.

Authors:  Rasmus Hytting-Andreasen; Emilie Balk-Møller; Bolette Hartmann; Jens Pedersen; Johanne Agerlin Windeløv; Jens Juul Holst; Hannelouise Kissow
Journal:  PLoS One       Date:  2018-06-04       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.